Investigation of usefulness of high speed crosslinking

Investigation of usefulness of high speed crosslinking - Investigation of usefulness of high speed crosslinking

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000031967

Enrollment

Registered

2018-04-01

Start date

2018-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Keratoconus, Percussive corneal degeneration, Keratectasia, Infective keratitis, Bullous keratopathy, Refractive abnormality

Interventions

Prevention of disease progression by collagen crosslinking to the cornea. After instillation of Paracel 2 (0.22% riboflavin, physiological saline), Ultraviolet rays with a wavelength of 365 nm are

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Progressive keratoconus, Percussive corneal degeneration, Keratectasia, Infectious keratitis, Bullous keratopathy, Refractive abnormality

Exclusion criteria

Exclusion criteria: Those who satisfy at least one of the following conditions

Design outcomes

Primary

Measure	Time frame
Vision, intraocular pressure, corneal refractive power, corneal thickness, complications	—

Countries

Japan

Contacts

Public ContactYosai Mori

Miyata Eye Hospital Ophthalmology Department

mori@miyata-med.ne.jp0986221441

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026